100%

Scanned image of the page. Keyboard directions: use + to zoom in, - to zoom out, arrow keys to pan inside the viewer.

Page Options

Share

Something wrong?

Something wrong with this page? Report problem.

Rights / Permissions

The University of Michigan Library provides access to these materials for educational and research purposes. These materials may be under copyright. If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission. If you have questions about the collection, please contact the Bentley Historical Library at bentley.ref@umich.edu

February 13, 1998 - Image 130

Resource type:
Text
Publication:
The Detroit Jewish News, 1998-02-13

Disclaimer: Computer generated plain text may have errors. Read more about this.

Business

We are pleased to announce that

Sheldon L. Rosenberg

has joined our firm as a
Senior Vice President-Investments

and

Alan Gildenberg

has joined our firm as a
Vice President-Investments
in our Bloomfield Hills office.

SERVING SERIOUS INVESTORS SINCE 1919
Stocks • Bonds • Mutual Funds
Annuities • U.S. Treasuries • Managed Accounts

Powerful Ideas. Powerful Results.

asird

MUTUAL COMPANY

Robert W. Baird & Co. Incorporated. 200 East Long Lake Rd., Bloomfield Hills, MI 48304.
Phone 248-594-9959. Member New York Stock Exchange, Inc. and other
principal exchanges. Member SIPC. Toll Free 1-888-594-9959. ‘vww.rwbaircl.com
©1998 Robert W. Baird & Co. Incorporated.

FINAL WINTER CLFARANCE!

SAVE vs 70%

MENS

WOMENS • CHILDREN
SHOES & BOOTS

Cruise Footwear Arriving . Daily

G re g

SHOES

ORCHARD IVIAkILIL
Orchard Lake Rd. • N. of Maple

W. Bloomfield • 248-851-5566

"Serving the communityfir over 40 years"

Is YOUR FINANCIAL HOUSE IN ORDER?

To find out, call

PHASE FOUR

JOEL LEVI, CFP
TRISH WELLMAN, CFP

(248) 559-6980

17117 WEST 9 MILE ROAD • SOUTHFIELD, MI 48075

PHASE FOUR ADVISORY, REGISTERED INVESTMENT ADVISOR

Securities offered through Vestax Securities Corporation, Member NASD & SIPC
1931 Georgetown, Hudson, OH 44236 • (216) 650-1660

Call The Sales Department
(248) 354-7123 Ext. 209

DETROIT
JEWISH NEWS

2/13

1998

130

Advertise in our Entertainment Section!

IT N

that quality chocolate comes only
from abroad," said Brenner. "That's
why all the printing on the boxes and
all our publicity are only in English."
Brenner has become known as a
savvy marketing and public-relations
man who brought the Max Brenner
name to the media forefront. But he
insists that the publicity came to
them.
Just a few weeks after they opened
and word got around that hand-made
chocolates had come to Israel, "all the
talk shows were calling us, the chil-
dren's programs wanted us to demon-
strate chocolate-making. We were
overwhelmed."
Brenner admits he is more interest-
ed in marketing and packaging his
product than in tinkering with recipes.
He is committed to the Chaudun tra-
dition (he flies to France to meet with
his "master" every month). Brenner
loves fashion and believes that choco-
late should not only taste good but be
stylish as well. His idol is designer
Jean-Paul Gaultier. Brenner's
store contains a homage
to Gaultier in the
form of his famous
bustiers sculpted in
chocolate. And he
aspires to market the
Max Brenner name in
chocolate the way world-
famous fashion designers parlay their
name into a range of products.
If Oded Brenner is attracted to the
art of chocolate-making, Ruthi
Melamed is more drawn to the science
of it. And while Brenner is living
large, Melamed — at least for now —
is happy thinking small. •
Her spotless modest shop, Ruthi's
Chocolates in Ramat Hasharon,
opened just half a year ago, is an
unobtrusive part of a largely residen-
tial neighborhood. Neat rows of
chocolate and truffles, dark chocolate,
white chocolate and cinnamon stand
in wait for customers, as well as
chocolate in the shape of small ani-
mals. She shuttles between the kitchen
and the counter, patiently explaining
the composition of each chocolate to
her customers. Keeping a personal
touch in her shop is important to her.
Unlike Brenner, Melamed followed
a careful course of study for three and
a half years, learning the principles of
temperatures, gradually moving into
making the most basic kinds of choco-
lates, such as chocolate-covered
almonds, and slowly moving into
more complicated chocolates with var-
ious layers of fillings. Her chocolate

"guru," as she calls him, is a Belgian
chef named Denief. Much of the sci-
ence of chocolate, she explains, has to
do with temperature. She points to a
machine in her kitchen that continu-
ously stirs a pool of chocolate.
"This is called 'tempering' - when
chocolate is raw." The chocolate she
uses, which is dull and rough looking,
is imported from Belgium. The
process of heating and cooling and
stirring is what makes it into the stiff,
shiny stuff we crave.
Melamed enjoys experimenting
with recipes and putting her own spe-
cial stamp on her product. She is par-
ticularly proud of her chocolate filled
with honey and a pine nut on top
(keeping the honey properly liquefied
is her own innovation) and her rose-
water-filled chocolates. She bridles at
the suggestion that she is riding on
Max Brenner's coattails.
"The idea of returning from
Belgium and having a chocolate shop
in Israel was my dream from the
beginning. The fact that Max
Brenner opened his place
a few years before I
returned was purely
coincidence."
She says her trim
figure belies her
weakness for the deli-
cacy she produces. "I'm
quite capable of going through a
whole box, no problem." Her philoso-
phy is that most things — but partic-
ularly chocolate — are fine in modera-
tion. "I have a theory that chocolate is
good for your soul. If you don't
indulge every day, but once in a while,
it is a good thing."



InterPharm Gears
To Market Drug

Jerusalem (JPFS) — InterPharm, the
Rehovot-based subsidiary of Ares-
Serono, is to establish a second plant,
at an investment of $20 million, to
produce the ingredient for its multiple
sclerosis drug Rebif, company presi-
dent Alex Kotzer announced. The
drug has undergone extensive clinical
trials and will soon be marketed in
Europe
Kotzer said the decision to double
production is based on the estimate
that Rebif will capture a significant
market share in MS drugs
Rebif, made from recombinant
interferon-beta, has been shown to
reduce the advancement and severity
of the disease.

.

.

Back to Top

© 2025 Regents of the University of Michigan